Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
about
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesPeptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategyLarge-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.Trial Watch: Peptide-based anticancer vaccines.Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.Cancer Immunotherapy Targeted Glypican-3 or Neoantigens.Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors.
P2860
Q26999045-A1C1CF76-3973-42B6-BB83-C563BCAE4296Q27020970-DBEFA31B-CC9E-405A-A6DC-CAA7B88144B9Q34372167-1977C95C-86A8-488D-9AB8-310EB8E64949Q34483345-9B4CE0C8-A807-4C96-BE0F-CA6A7020DC2EQ34548226-7C4AAE9E-08BD-473D-8DA8-A649CDED6AE7Q36684407-13F18630-1A1B-4573-9C03-244566A46B6DQ39149552-AE627994-CC95-4F1C-9892-26D962E1FBD7Q39378285-4633A9F8-02D9-4912-A919-FF8600B3F169Q41683191-DDB30C5F-D2D2-4485-AE74-770755CE6AAAQ47760070-67CB7068-3480-49C8-97E0-5C4FEBA9D390Q48248569-8F9C08F3-369B-4D3A-B9B2-0C99D73B04CB
P2860
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intratumoral peptide injection ...... specific cancer immunotherapy.
@ast
Intratumoral peptide injection ...... specific cancer immunotherapy.
@en
type
label
Intratumoral peptide injection ...... specific cancer immunotherapy.
@ast
Intratumoral peptide injection ...... specific cancer immunotherapy.
@en
prefLabel
Intratumoral peptide injection ...... specific cancer immunotherapy.
@ast
Intratumoral peptide injection ...... specific cancer immunotherapy.
@en
P2093
P2860
P1476
Intratumoral peptide injection ...... specific cancer immunotherapy.
@en
P2093
Daisuke Nobuoka
Hiroshi Sadamori
Kazutaka Horie
Manami Shimomura
Munehide Nakatsugawa
Noriko Sakemura
Shiro Suzuki
Takahito Yagi
Tatsuaki Iwama
Tetsuya Nakatsura
P2860
P2888
P304
P356
10.1007/S00262-012-1366-6
P577
2012-11-11T00:00:00Z